跳至主要内容
临床试验/NCT06496022
NCT06496022进行中(未招募)不适用

Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome

Asfendiyarov Kazakh National Medical University1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
600
试验地点
1
主要终点
frailty prevalence

研究概览

简要总结

Assessing frailty syndrome in elderly patients in Almaty To study the features of the clinical course in the group of patients with a pre-frailty and in the group with frailty syndrome

详细描述

2 cohorts of patients: a group of patients with pre-frailty (300 patients) and a group of patients with frailty syndrome (300 patients).

Comparative analysis of the indicators of two groups (demographic, laboratory indicators, scale results).

To study the features of the clinical course of frailty. To determine the risk factors for the development of frailty. To identify criteria for an unfavorable outcome of frailty.

The study will involve patients over the age of 60. The recruitment of patients will be carried out in polyclinics and nursing homes in Kazakhstan.

The collection of primary information and a comprehensive examination of patients will be based on the following research methods recommended by WHO:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 60 years of age
  • Signatories of the informed consent to participate in the study

排除标准

  • Not agreeing to participate in scientific research
  • Elderly people who do not understand the purpose of the study
  • Severe and decompensated diseases that do not allow the study.
  • Concomitant oncological diseases
  • Concomitant neurological and mental disorders that impede the study

结局指标

主要结局

frailty prevalence

时间窗: 1 March 2024 - 31 December 2024

A FRAIL scale or Fried frailty criteria is used (weight loss, exhaustion, low physical activity, slowness, weakness). The participants were divided into three stages: non-frail (score 0), pre-frail (score 1-2) and frail (score 3-5).

次要结局

未报告次要终点

研究者

发起方
Asfendiyarov Kazakh National Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Indira Omarova

Principal Investigator, Assistant of the department of General Medical Practice

Asfendiyarov Kazakh National Medical University

研究点 (1)

Loading locations...

相似试验